The National Center for Cancer Care and Research (NCCCR) of Hamad Medical Corporation’s Blood and Marrow Transplant Program has grown its services throughout time and helped many patients save their lives.
According to a senior physician at NCCCR, the highly developed Blood and Marrow Stem Cell Transplant Program (BMT Program) has produced notable results in patient care. As the only Adult Hematopoietic Stem Cell Transplant Program in Qatar, the BMT Program at NCCCR seeks to provide comprehensive, compassionate treatment while advancing the science of hematopoietic cell transplantation and enhancing patient outcomes. “Interdisciplinary expert teams of transplant physicians, transplant nurses, transfusion medicine, laboratory medicine and stem cell processing laboratory have invested years of developmental work to finally establish this cutting-edge Blood and Marrow Stem Cell Transplant Program,” Senior Consultant and Chairman of Hematology and BMT Department at NCCCR Dr. Javid Gaziev said. A BMT is a very effective treatment and frequently the only chance for individuals with blood malignancies to be cured or live a longer life. In this surgery, healthy bone marrow stem cells are used to replace damaged bone marrow. It helps patients’ blood and immune systems recover while removing malignant or damaged stem cells.